Profilo
Olivier Bataille is currently the Chief Operations Officer at MY01, Inc. He previously worked at CryoCath Technologies, Inc. as the Vice President of Product Development and Operations.
Posizioni attive di Olivier Bataille
| Società | Posizione | Inizio |
|---|---|---|
MY01, Inc.
 MY01, Inc. Medical SpecialtiesHealth Technology MY01, Inc. is a Canadian healthcare technology company that aims to improve patient outcomes by providing objective data to aid in the diagnosis of compartment syndrome. MY01 is based in an undisclosed location since 2015 and leverages its expertise in microsensing technology to provide innovative diagnostic solutions. The company believes that adding actionable, quantitative data at the bedside can augment clinical assessments to provide more effective care. The company was founded in 2015 by Charles Allan, George Xereas, and Edward Harvey, with Charles Allan serving as the CEO since then. | Direttore operativo | 01/05/2019 |
Precedenti posizioni note di Olivier Bataille
| Società | Posizione | Fine |
|---|---|---|
CryoCath Technologies, Inc.
 CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Direttore operativo | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
CryoCath Technologies, Inc.
CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Health Technology |
MY01, Inc.
MY01, Inc. Medical SpecialtiesHealth Technology MY01, Inc. is a Canadian healthcare technology company that aims to improve patient outcomes by providing objective data to aid in the diagnosis of compartment syndrome. MY01 is based in an undisclosed location since 2015 and leverages its expertise in microsensing technology to provide innovative diagnostic solutions. The company believes that adding actionable, quantitative data at the bedside can augment clinical assessments to provide more effective care. The company was founded in 2015 by Charles Allan, George Xereas, and Edward Harvey, with Charles Allan serving as the CEO since then. | Health Technology |
- Borsa valori
- Insiders
- Olivier Bataille
